Revised International Prognostic Index

The Revised International Prognostic Index is used to determine prognosis in PATIENTS with Diffuse Large B-cell Lymphoma (DLBCL).

Also Known As

This NHS business definition is also known by these names:

Context Alias
Short name R-IPI